Ernexa Therapeutics adds $5,000 monthly cash compensation for CFO Mark Keeley
ERNA•Ernexa Therapeutics will pay CFO Mark J. Keeley $5,000 monthly in cash, supplementing his existing share-based compensation. The board approved the addendum on November 14, effective November 9, with November compensation prorated.
1. Cash compensation addendum
Ernexa Therapeutics will pay CFO Mark J. Keeley $5,000 monthly in cash under an addendum to his consulting agreement, supplementing his existing share-based compensation. The board approved the addendum on November 14, 2026, effective November 9; November's payment will be prorated. All other terms of the August 10, 2026 agreement remain unchanged.




